NR3C2 and cardiovascular disorder: Overactivity of the mineralocorticoid receptor (MR) has a central role in the pathophysiology of CKD and cardiovascular disease (CVD) through inflammation and fibrogenic pathways within cardiac and kidney tissues [4].